F2RL1 and hepatocellular carcinoma: Therefore, we confirm that assessment of PAR2 expression could potentially help to predict the outcome of patients with HCC; patients with high expression of PAR2 may benefit from more intensive surveillance and timely adjuvant treatment to improve their prognosis.